Press Releases about Cybin Inc
![](https://mms.businesswire.com/media/20231110475603/en/1908939/22/Cybin_Side_Logo.jpg)
Cybin Announces up to US$64 Million Offering of Units
November 10, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231103920876/en/1908939/22/Cybin_Side_Logo.jpg)
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231101253136/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://mms.businesswire.com/media/20231031220551/en/1929735/22/Treatment_landscape.jpg)
![](https://mms.businesswire.com/media/20231026710162/en/1908939/22/Cybin_Side_Logo.jpg)
Cybin Announces Grant of European Patent Protecting its Proprietary Deuterated Programs
October 26, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231025315693/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://mms.businesswire.com/media/20231022071953/en/1922116/5/Small_Pharma_Logo_Final_002147-01_Oxford_Blue.jpg)
![](https://mms.businesswire.com/media/20231017215015/en/1918265/5/Small_Pharma_Logo_Final_002147-01_Oxford_Blue_%282%29.jpg)
Small Pharma Obtains Final Order Approving Arrangement
October 17, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231012302314/en/1908939/22/Cybin_Side_Logo.jpg)
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231006424632/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://mms.businesswire.com/media/20231004309675/en/1906466/22/Cybin_Side_Logo_%28004%29.jpg)
Cybin to Present at the Jefferies Inaugural Biotech CNS/Neuro Summit
October 04, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231003190038/en/1904925/22/Cybin_Side_Logo.jpg)
![](https://mms.businesswire.com/media/20230927069776/en/1900342/22/Cybin_Side_Logo.jpg)
![](https://mms.businesswire.com/media/20230926212750/en/1899040/22/Cybin_Side_Logo.jpg)
![](https://mms.businesswire.com/media/20230925617402/en/1897750/22/Cybin_Side_Logo_%28004%29.jpg)
Cybin to Participate in the Cantor Global Healthcare Conference
September 25, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230921821461/en/1896866/22/Cybin_Side_Logo.jpg)
Cybin Announces Date of Annual and Special Meeting of Shareholders
September 21, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230921411645/en/1896011/22/Cybin_Side_Logo.jpg)
Cybin Completes Enrollment in Phase 2 Study of CYB003 in Major Depressive Disorder
September 21, 2023
From Cybin Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.